Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 6
Submit an article Journal homepage
289
Views
10
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Drug safety and efficacy evaluation of sertindole for schizophrenia

Evangelos KaramatskosUniversity Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr. 52, D-20246 Hamburg, Germany+49 40 7410 57601; +49 40 7410 58013; [email protected]
,
Martin LambertUniversity Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr. 52, D-20246 Hamburg, Germany+49 40 7410 57601; +49 40 7410 58013; [email protected]
,
Christoph MulertUniversity Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr. 52, D-20246 Hamburg, Germany+49 40 7410 57601; +49 40 7410 58013; [email protected]
&
Dieter NaberUniversity Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistr. 52, D-20246 Hamburg, Germany+49 40 7410 57601; +49 40 7410 58013; [email protected]
Pages 1047-1062 | Published online: 19 Sep 2012

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Haiyun Xu & Xiaoyin Zhuang. (2019) Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review. Neuropsychiatric Disease and Treatment 15, pages 2087-2099.
Read now
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Maria Rosaria Anna Muscatello, Antonio Bruno, Paolo Micali Bellinghieri, Gianluca Pandolfo & Rocco Antonio Zoccali. (2014) Sertindole in schizophrenia: efficacy and safety issues. Expert Opinion on Pharmacotherapy 15:13, pages 1943-1953.
Read now
Chi-Un Pae. (2013) Sertindole: dilemmas for its use in clinical practice. Expert Opinion on Drug Safety 12:3, pages 321-326.
Read now

Articles from other publishers (6)

Yusheng Qu, Guy Page, Najah Abi-Gerges, Paul E. Miller, Andre Ghetti & Hugo M. Vargas. (2018) Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae. Frontiers in Physiology 8.
Crossref
Andy Wolff, Revan Kumar Joshi, Jörgen Ekström, Doron Aframian, Anne Marie Lynge Pedersen, Gordon Proctor, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Ardita Aliko, Richard McGowan, Alexander Ross Kerr, Siri Beier Jensen, Arjan Vissink & Colin Dawes. (2016) A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D 17:1, pages 1-28.
Crossref
Lan Chi VoChristopher SnyderCourtney McCrackenChristopher J. McDougleJames T. McCrackenMichael G. AmanElaine TierneyL. Eugene ArnoldDaniel LeviMichael KellemanDeirdre CarrollJohn MorrisseyBenedetto VitielloLawrence Scahill. (2016) No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology 26:10, pages 900-908.
Crossref
Xichun Li, Rui Zhang, Bin Zhao, Christoph Lossin & Zhengyu Cao. (2015) Cardiotoxicity screening: a review of rapid-throughput in vitro approaches. Archives of Toxicology 90:8, pages 1803-1816.
Crossref
Rocco A. Zoccali, Antonio Bruno & Maria Rosaria Anna Muscatello. (2015) Efficacy and Safety of Sertindole in Schizophrenia. Journal of Clinical Psychopharmacology 35:3, pages 286-295.
Crossref
Jimmi Nielsen, Fan Wang, Claus Graff & Jørgen K. Kanters. (2014) QT dynamics during treatment with sertindole. Therapeutic Advances in Psychopharmacology 5:1, pages 26-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.